Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGF1R | P08069 | 20/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.67 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6093894 | 1.00 | IGF1R (0.67) | IGF1RCYP3A4CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL3997972 | 0.93 | IGF1R (0.78) | IGF1RCYP3A4CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL3997969 | 0.93 | IGF1R (0.78) | IGF1RCYP3A4CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL6096307 | 0.91 | IGF1R (0.65) | IGF1RCYP3A4CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL6096299 | 0.91 | IGF1R (0.65) | IGF1RCYP3A4CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL5074379 | 0.88 | IGF1R (0.70) | IGF1RCYP3A4CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL5074383 | 0.88 | IGF1R (0.70) | IGF1RCYP3A4CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL6094953 | 0.87 | IGF1R (0.60) | IGF1RCYP3A4CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL6094962 | 0.87 | IGF1R (0.60) | IGF1RCYP3A4CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL6094076 | 0.85 | IGF1R (0.70) | IGF1RCYP3A4CYP1A2CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7223757-B2 | Tyrosine kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-05-29 | — | — | US | disclosed |
| US-7081454-B2 | Tyrosine kinase inhibitors | BRISTOL-MYERS SQUIBB CO. (US) | 2006-07-25 | — | — | US | disclosed |